A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris
Status:
Terminated
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the biologic medication alefacept (Amevive)
is effective and safe in the treatment of Pityriasis Rubra Pilaris.
Phase:
Phase 4
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai Joshua Zeichner